LUND, SE / ACCESS Newswire / March 18, 2026 / Cantargia (STO:CANTA) today reported the presentation of new pre-clinical data highlighting how a murine surrogate antibody to nadunolimab, an anti-IL1RAP ...
Avacta Announces Preclinical and Translational Presentations of pre|CISION® Platform Candidates at the 2026 AACR Annual Conference ...
BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced that Nathan Fowler, MD, Chief Medical Officer at BostonGene will deliver multiple presentations ...
Cancer immunotherapy has transformed the treatment landscape for multiple malignancies; however, its clinical efficacy remains limited in many tumors due to ...
Bicara Therapeutics (NASDAQ:BCAX) is developing tumor-targeting bifunctional antibodies, with its lead candidate ficerasfusp alfa designed to address both EGFR and TGF-beta biology in cancer, company ...
This Research Topic is the second volume of the “Unraveling Breast Cancer Complexity: Insights from Single-Cell Sequencing and Spatial Transcriptomics” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results